Age- and gender-specific risk of death after first hospitalization for heart failure

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Vaartjes, I ^a   Hoes, A W ^a   Reitsma, J B ^b   De Bruin, A ^c   Grobbee, D E ^a   Mosterd, A ^a,d   Bots, M L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c STATISTICS NETHERLANDS   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; REGISTER; RISK FACTOR; STATISTICS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; REGISTRIES; RISK FACTORS;

EID: 77958040090     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-637     Document Type: Article

References (36)

1. Clinical epidemiology of heart failure. A Mosterd AW Hoes, Heart 2007 93 1137 1146 10.1136/hrt.2003.025270 17699180
2. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. MM Redfield SJ Jacobsen JC Burnett Jr DW Mahoney KR Bailey RJ Rodeheffer, JAMA 2003 289 194 202 10.1001/jama.289.2.194 12517230
3. The health and economic burden of rotavirus disease in Belgium. J Bilcke P Van Damme F De Smet G Hanquet M Van Ranst P Beutels, Eur J Pediatr 2008 67 1409 1419 10.1007/s00431-008-0684-3
4. Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure. SP Collins DP Schauer A Gupta H Brunner AB Storrow MH Eckman, Am J Emerg Med 2009 27 293 302 10.1016/j.ajem.2008.02.025 19328373
5. Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure. G Miller S Randolph E Forkner B Smith AD Galbreath, Med Decis Making 2009 29 325 33 10.1177/0272989X08327494 19147835
6. Predictors of short term mortality in heart failure - Insights from the Euro Heart Failure survey. P Velavan NK Khan K Goode AS Rigby PH Loh M Komajda F Follath K Swedberg H Madeira JG Cleland, Int J Cardiol 2010 138 63 69 10.1016/j.ijcard.2008.08.004 18789548
7. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. SD Solomon J Dobson S Pocock H Skali JJ McMurray CB Granger S Yusuf K Swedberg JB Young EL Michelson MA Pfeffer, Circulation 2007 116 1482 1487 10.1161/CIRCULATIONAHA.107.696906 17724259
8. Long-term outcome after a first episode of heart failure. A prospective 7-year study. C Tribouilloy O Buiciuc D Rusinaru D Malaquin F Levy M Peltier, Int J Cardiol 2010 140 309 14 10.1016/j.ijcard.2008.11.087 19100635
9. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). M Galvao J Kalman T DeMarco GC Fonarow C Galvin JK Ghali RM Moskowitz, J Card Fail 2006 12 100 107 10.1016/j.cardfail. 2005.09.005 16520256
10. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. PS Jhund K Macintyre CR Simpson JD Lewsey S Stewart A Redpath JW Chalmers S Capewell JJ McMurray, Circulation 2009 119 515 523 10.1161/CIRCULATIONAHA.108.812172 19153268
11. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. M Shafazand M Schaufelberger G Lappas K Swedberg A Rosengren, Eur Heart J 2009 30 671 678 10.1093/eurheartj/ehn541 19109351
12. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. S Stewart K Macintyre DJ Hole S Capewell JJ McMurray, Eur J Heart Fail 2001 3 315 322 10.1016/S1388-9842(00)00141-0 11378002
13. Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. SS Rathore JM Foody Y Wang J Herrin FA Masoudi EP Havranek DL Ordin HM Krumholz, Am Heart J 2005 149 121 128 10.1016/j.ahj.2004.06.008 15660043 (Pubitemid 40126499)
14. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. M Schaufelberger K Swedberg M Koster M Rosen A Rosengren, Eur Heart J 2004 25 300 307 10.1016/j.ehj.2003.12.012 14984918
15. Risk of death after first admission for cardiovascular diseases by country of birth in The Netherlands: a nationwide record-linked retrospective cohort study. C Agyemang I Vaartjes ML Bots I Valkengoed van JS de Munter A de Bruin SM Berger-van JB Reitsma K Stronks, Heart 2009 95 747 753 10.1136/hrt.2008.159285 19164329
16. Possibilities for anonymous follow-up studies of patients in Dutch national medical registrations using the Municipal Population Register: a pilot study. JB Reitsma JW Kardaun E Gevers A de Bruin J van der Wal GJ Bonsel, Ned Tijdschr Geneeskd 2003 147 2286 2290 14655296
17. Survival of patients with a new diagnosis of heart failure: a population based study. MR Cowie DA Wood AJ Coats SG Thompson V Suresh PA Poole-Wilson GC Sutton, Heart 2000 83 505 510 10.1136/heart.83.5.505 10768897
18. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. HM Krumholz J Butler J Miller V Vaccarino CS Williams CF Mendes de Leon TE Seeman SV Kasl LF Berkman, Circulation 1998 97 958 964 9529263
19. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). LR Loehr WD Rosamond PP Chang AR Folsom LE Chambless, Am J Cardiol 2008 101 1016 1022 10.1016/j.amjcard.2007.11.061 18359324
20. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. JE Blair F Zannad MA Konstam T Cook B Traver JC Burnett Jr L Grinfeld H Krasa AP Maggioni C Orlandi K Swedberg JE Udelson C Zimmer M Gheorghiade, J Am Coll Cardiol 2008 52 1640 1648 10.1016/j.jacc.2008.07.056 18992654
21. Gender differences in advanced heart failure: insights from the BEST study. JK Ghali HJ Krause-Steinrauf KF Adams SS Khan YD Rosenberg CW Yancy JB Young S Goldman MA Peberdy J Lindenfeld, J Am Coll Cardiol 2003 42 2128 2134 10.1016/j.jacc.2003.05.012 14680739 (Pubitemid 37549897)
22. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. E O'Meara T Clayton MB McEntegart JJ McMurray IL Pina CB Granger J Ostergren EL Michelson SD Solomon S Pocock S Yusuf K Swedberg MA Pfeffer, Circulation 2007 115 3111 3120 10.1161/CIRCULATIONAHA.106.673442 17562950
23. Gender differences in acute congestive heart failure. M Ritter K Laule-Kilian T Klima A Christ M Christ A Perruchoud C Mueller, Swiss Med Wkly 2006 136 311 317 16741854
24. The epidemiology of heart failure. MR Cowie A Mosterd DA Wood JW Deckers PA Poole-Wilson GC Sutton DE Grobbee, Eur Heart J 1997 18 208 225 9043837
25. The epidemiology of heart failure: the Framingham Study. KK Ho JL Pinsky WB Kannel D Levy, J Am Coll Cardiol 1993 22 6A 13A 10.1016/0735-1097(93)90455-A 8376698
26. Why are patients in clinical trials of heart failure not like those we see in everyday practice? F Lloyd-Williams F Mair C Shiels B Hanratty P Goldstein S Beaton S Capewell M Lye R Mcdonald C Roberts D Connelly, J Clin Epidemiol 2003 56 1157 1162 10.1016/S0895-4356(03)00205-1 14680665
27. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. KK Ho KM Anderson WB Kannel W Grossman D Levy, Circulation 1993 88 107 115 8319323
28. Prevalence and mortality rate of congestive heart failure in the United States. DD Schocken MI Arrieta PE Leaverton EA Ross, J Am Coll Cardiol 1992 20 301 306 10.1016/0735-1097(92)90094-4 1634664
29. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J. MG Bourassa O Gurne SI Bangdiwala JK Ghali JB Young M Rousseau DE Johnstone S Yusuf, Am Coll Cardiol 1993 22 14A 19A 10.1016/0735-1097(93)90456-B
30. Relation between gender, etiology and survival in patients with symptomatic heart failure. KF Adams Jr SH Dunlap CA Sueta SW Clarke JH Patterson MB Blauwet LR Jensen L Tomasko G Koch, J Am Coll Cardiol 1996 28 1781 1788 10.1016/S0735-1097(96)00380-4 8962567
31. Research on the validity of the LMR [In Dutch]. GRA Paas KCW Veenhuizen, Prismant: Utrecht 2002
32. Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort study. AH Merry JM Boer LJ Schouten EJ Feskens WM Verschuren AP Gorgels PA van den Brandt, Eur J Epidemiol 2009 24 237 247 10.1007/s10654-009-9335-x 19337843
33. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. DS Lee L Donovan PC Austin Y Gong PP Liu JL Rouleau JV Tu, Med Care 2005 43 182 188 10.1097/00005650- 200502000-00012 15655432
34. Certification and coding of two underlying causes of death in The Netherlands and other countries of the European Community. JP Mackenbach WM van Duyne MC Kelson, J Epidemiol Community Health 1987 41 156 160 10.1136/jech.41.2.156 3655636
35. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. HM Krumholz EM Parent N Tu V Vaccarino Y Wang MJ Radford J Hennen, Arch Intern Med 1997 157 99 104 10.1001/archinte.157.1.99 8996046
36. Readmissions and the quality of care in patients hospitalized with heart failure. JC Luthi MJ Lund L Sampietro-Colom DG Kleinbaum DJ Ballard WM McClellan, Int J Qual Health Care 2003 15 413 421 10.1093/intqhc/mzg055 14527985